OnkoRiskTM Hereditary Cancer Program

GenPath® is a proud leading provider of cutting-edge cancer diagnostics with industry-leading turnaround times. GenPath offers a comprehensive test portfolio to provide a single-source solution to support the continuum of care of cancer patients. Backed by a team of specialized board-certified pathologists, GenPath delivers a wide range of diagnostic oncology solutions that meet the unique needs of oncologists and pathologists, ranging from routine clinical and special coagulation testing to complex genomic testing for tumor sequencing, and hereditary cancer syndromes.

OnkoRiskTM Hereditary Cancer Program Include:

  • Streamlined test menu
  • Rapid turnaround times at 14 days*
  • Pre- and post-test genetic education and counseling
  • Transparent billing policy
  • Guideline-driven gene content and reporting supported by board-certified medical experts

Benefits of Genetic Testing for Hereditary Cancer

  • Engage in personalized medicine such as the use of PARP inhibitors
  • Assess patient and family risk for recurrent, potentially aggressive, or other genetically related cancers
  • Consideration of reproductive management, such as fertility preservation
  • Qualify patients for clinical trials for gene variants in BRCA1, ATM, and many others

*Turnaround times are typical and begin once the specimen is received at the laboratory but could be extended in situations outside GenPath’s reasonable control.